Group B coxsackieviruses and autoimmunity: Focus on Type 1 diabetes

Expert Review of Clinical Immunology

Volumn 7, Issue 3, 2011, Pages 357-366

  Sané, Famara ^a   Moumna, Ilham ^a   Hober, Didier ^a  

^a University Lille   (France)

Author keywords

autoimmunity; Group B coxsackieviruses; islet cells; Type 1 diabetes

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3;

ADAPTIVE IMMUNITY; ANTIBODY DEPENDENT ENHANCEMENT; AUTOIMMUNITY; BYSTANDER EFFECT; CELL DESTRUCTION; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTERFERON PRODUCTION; MOLECULAR MIMICRY; NONHUMAN; PANCREAS ISLET BETA CELL; PERSISTENT INFECTION; REVIEW; THYMUS DISEASE;

AUTOIMMUNITY; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; HUMANS;

EID: 79957498435     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.11     Document Type: Review

References (110)

1. Selmi C. Autoimmunity in 2009 Autoimmun. Rev. 9(12), 795-800 (2010).
2. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347(12), 911-920 (2002).
3. Goldberg E, Krause I. Infection and Type 1 diabetes mellitus-a two edged sword? Autoimmun. Rev. 8(8), 682-686 (2009).
4. Hober D, Sane F. Enteroviral pathogenesis of Type 1 diabetes. Discov. Med. 10(51), 151-160 (2010).
5. Pallansch MA, Roos RP, Knipe DM. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields Virology 2007 (5th Ed.).Lippincott Williams & Wilkins, PA, USA, 839-894 (2006).
6. Oberste MS. Comparative genomics of the coxsackie B viruses and related enteroviruses. Curr. Top. Microbiol. Immunol. 323, 33-47 (2008).
7. Kallewaard NL, Zhang L, Chen JW, Guttenberg M, Sanchez MD, Bergelson JM. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe. 6(1), 91-98 (2009).
8. Tracy S, Oberste MS, Drescher KM. Group B coxsackieviruses. In: Current Topics in Microbiology and Immunology (Volume 323).Springer, Berlin, Germany 293-309 (2008).
9. Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of Type 1 diabetes. Diabetes Metab. 34(6 Pt 1), 537-548 (2008).
10. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human Type 1 diabetes. Diabetologia 52(6), 1143-1151 (2009).
11. Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr. Top. Micobiol. Immunol. 323, 315-335 (2008).
12. Ylipaasto P, Klingel K, Lindberg AM et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet b cells. Diabetologia 47(2), 225-39 (2004). (Pubitemid 38315359)
13. Chehadeh W, Kerr-Conte J, Pattou F et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with a interferon synthesis in b cells. J. Virol. 74(21), 10153-10164 (2000).
14. Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76(9), 4430-4440 (2002). (Pubitemid 34309580)
15. Chaplin DD. Overview of the immune response. J. Allergy Clin. Immunol. 125(2 Suppl. 2), S3-S23 (2010).
16. Ylipaasto P, Kutlu B, Rasilainen S et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 48(8), 1510-1522 (2005). (Pubitemid 41175504)
17. Rasschaert J, Ladrière L, Urbain M et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-g-induced apoptosis in primary pancreatic b-cells. J. Biol. Chem. 280(40), 33984-33991 (2005). (Pubitemid 41443119)
18. Dogusan Z, García M, Flamez D et al. Double-stranded RNA induces pancreatic b-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 57(5), 1236-1245 (2008).
19. Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344(1), 119-130 (2006). (Pubitemid 41814456)
20. Hühn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodström- Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection. Virology 401(1), 42-48 (2010).
21. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against Type 1 diabetes. Science 324(5925), 387-389 (2009).
22. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and b-cell loss in Type 1 diabetes. Nat. Rev. Endocrinol. 5(4), 219-226 (2009).
23. Triantafilou K, Orthopoulos G, Vakakis E et al. Human cardiac inflammatory responses triggered by coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol. 7(8), 1117-1126 (2005). (Pubitemid 41030937)
24. Wang JP, Asher DR, Chan M, Kurt- Jones EA, Finberg RW. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J. Immunol. 178(6), 3363-3367 (2007). (Pubitemid 46417599)
25. Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS ONE 4(1), e4127 (2009).
26. Hultcrantz M, Hühn MH, Wolf M et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology 367(1), 92-101 (2007). (Pubitemid 47418925)
27. Hühn MH, Hultcrantz M, Lind K, Ljunggren HG, Malmberg KJ, Flodström- Tullberg M. IFN-g production dominates the early human natural killer cell response to coxsackievirus infection. Cell Microbiol. 10(2), 426-436 (2008).
28. von Herrath M. Diabetes: a virus-gene collaboration. Nature 459(7246), 518-519 (2009).
29. Hühn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodström-Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection. Virology 401(1), 42-48 (2010).
30. Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 155(4), 1205-1215 (1999). (Pubitemid 29488928)
31. Misbah SA, Spickett GP, Ryba PC, Hockaday JM, Kroll JS, Sherwood C. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J. Clin. Immunol. 12(4), 266-270 (1992).
32. Schmugge M, Lauener R, Bossart W, Seger RA, Güngör T. Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment. Eur. J. Pediatr. 158(12), 1010-1011 (1999).
33. Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69(11), 6720-6728 (1995).
34. Skarsvik S, Puranen J, Honkanen J et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with Type 1 diabetes. Diabetes 55(4), 996-1003 (2006). (Pubitemid 44100174)
35. Hober D, Sauter P. Pathogenesis of Type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol. 6(5), 279-289 (2010).
36. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of Type 1 diabetes. Semin. Immunopathol. 33(1), 45-55 (2010).
37. Hober D, Sane F. Enteroviruses and Type 1 diabetes. Br. Med. J. 3, 342 (2011).
38. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and Type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br. Med. J. 3, 342 (2011).
39. Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and Type 1 diabetes: towards a better understanding of the relationship. Rev. Med. Virol. 20(5), 265-280 (2010).
40. Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on Type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148(1), 1-16 (2007). (Pubitemid 46364983)
41. Mariño E, Batten M, Groom J et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57(2), 395-404 (2008).
42. Haverkos HW, Battula N, Drotman DP, Rennert OM. Enteroviruses and Type 1 diabetes mellitus. Biomed. Pharmacother. 57(9), 379-385 (2003). (Pubitemid 37494713)
43. Green J, Casabonne D, Newton R. Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet. Med. 21, 507-514 (2004). (Pubitemid 38746267)
44. Gamble DR, Kinsley MJ, Fitzgerald MG et al. Viral antibodies in diabetes mellitus. Br. Med. J. 3, 627-630 (1969).
45. Yoon JW, Austin M, Onodera T et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis (virus-induced diabetes mellitus).N. Engl. J. Med. 300, 1173-1179 (1979). (Pubitemid 9191515)
46. Andréoletti L, Hober D, Hober- Vandenberghe C et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of Type I diabetes mellitus. J. Med. Virol. 52(2), 121-127 (1997). (Pubitemid 27239308)
47. Schulte BM, Bakkers J, Lanke KH et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of Type 1 diabetic patients beyond the stage of acute infection. Viral Immunol. 23(1), 99-104 (2010).
48. Toniolo A, Maccari G, Federico G, Salvatoni A, Bianchi G, Baj A. Are enterovirus infections linked to the early stages of Type 1 diabetes? Presented at: American Society for Microbiology Meeting. San Diego, CA, USA, 23-27 May 2010 (Abstract).
49. Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of Type 1 diabetic children at onset. Diabetes 51(6), 1964-1971 (2002). (Pubitemid 34564312)
50. Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gürtler L, Mentel R. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with Type 1-diabetes-associated autoantibodies. J. Med. Microbiol. 54(Pt 9), 879-883 (2005). (Pubitemid 41216286)
51. Kawashima H, Ihara T, Ioi H et al. Enterovirus-related Type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan. J. Infect. 49(2), 147-151 (2004). (Pubitemid 38967349)
52. Salminen KK, Vuorinen T, Oikarinen S et al. Isolation of enterovirus strains from children with preclinical Type 1 diabetes. Diabet. Med. 21(2), 156-164 (2004). (Pubitemid 38221815)
53. Dotta F, Censini S, van Halteren AG et al. Coxsackie B4 virus infection of b cells and natural killer cell insulitis in recent-onset Type 1 diabetic patients. Proc. Natl Acad. Sci. USA 104(12), 5115-5120 (2007). (Pubitemid 47186185)
54. Sadeharju K, Hämäläinen AM, Knip M et al. Enterovirus infections as a risk factor for Type I diabetes: virus analyses in a dietary intervention trial. Clin. Exp. Immunol. 132(2), 271-277 (2003). (Pubitemid 36560623)
55. Sarmiento L, Cabrera-Rode E, Lekuleni L et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed Type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of Type 1 diabetes. Autoimmunity 40(7), 540-545 (2007). (Pubitemid 351233176)
56. Oikarinen M, Tauriainen S, Honkanen T et al. Detection of enteroviruses in the intestine of Type 1 diabetic patients. Clin. Exp. Immunol. 151(1), 71-75 (2007).
57. Roivainen M, Klingel K. Role of enteroviruses in the pathogenesis of Type 1 diabetes. Diabetologia 52(6), 995-996 (2009).
58. Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, Type 1 diabetes. Ann. NY Acad. Sci. 1103, 143-151 (2007). (Pubitemid 46791110)
59. Elfving M, Svensson J, Oikarinen S et al. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with Type 1 diabetes between 15 and 30 years of age. Exp. Diabetes Res. 2008, 271958 (2008).
60. Lönnrot M, Salminen K, Knip M et al. Enterovirus RNA in serum is a risk factor for b-cell autoimmunity and clinical Type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J. Med. Virol. 61(2), 214-220 (2000). (Pubitemid 30257246)
61. Lönnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for b-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 49(8), 1314-1318 (2000). (Pubitemid 30624231)
62. Oikarinen S, Martiskainen M, Tauriainen S et al. Enterovirus RNA in blood is linked to the development of Type 1 diabetes. Diabetes 60(1), 276-279 (2011).
63. Jaidane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D. Coxsackievirus B4 and Type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab. Res. Rev. 25, 591-603 (2009).
64. Foulis AK, Farquharson MA, Meager A. Immunoreactive a-interferon in insulin-secreting b cells in Type 1 diabetes mellitus. Lancet 2(8573), 1423-1427 (1987). (Pubitemid 18010318)
65. Huang X, Yuang J, Goddard A et al. Interferon expression in the pancreases of patients with Type I diabetes. Diabetes 44(6), 658-664 (1995).
66. See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J. Infect. Dis. 171(5), 1131-1138 (1995).
67. Hyöty H. Enterovirus infections and Type 1 diabetes. Ann. Med. 34(3), 138-147 (2002). (Pubitemid 34804186)
68. Yin H, Berg AK, Westman J, Hellerström C, Frisk G. Complete nucleotide sequence of a coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J. Med. Virol. 68(4), 544-557 (2002). (Pubitemid 35231782)
69. Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human b cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45(5), 693-702 (2002). (Pubitemid 34810694)
70. Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. Induction of Type I diabetes by interferon-a in transgenic mice. Science 260(5116), 1942-1946 (1993). (Pubitemid 23258275)
71. Tam PE, Messner RP. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 73(12), 10113-10121 (1999).
72. Duncan G, Pelletier I, Colbère-Garapin F. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions. Virology 241(1), 14-29 (1998). (Pubitemid 28384209)
73. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4(7), 781-785 (1998). (Pubitemid 28331018)
74. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of Type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49(5), 708-711 (2000). (Pubitemid 30339984)
75. Horwitz MS, Fine C, Ilic A, Sarvetnick N. Requirements for viral-mediated autoimmune diabetes: b-cell damage and immune infiltration. J. Autoimmun. 16(3), 211-217 (2001). (Pubitemid 32566109)
76. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic b cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109(1), 79-87 (2002). (Pubitemid 34052544)
77. Rasche S, Busick RY, Quinn A. GAD65- specific cytotoxic T lymphocytes mediate b-cell death and loss of function. Rev. Diabet. Stud. 6(1), 43-53 (2009).
78. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366(6450), 69-72 (1993). (Pubitemid 23345238)
79. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366(6450), 72-75 (1993). (Pubitemid 23345239)
80. Horwitz MS, Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol. Rev. 169, 241-253 (1999).
81. Filippi CM, von Herrath MG. Viral trigger for Type 1 diabetes: pros and cons. Diabetes 57(11), 2863-2871 (2008).
82. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).J. Clin. Invest. 96(3), 1506-1511 (1995).
83. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA 87(4), 1576-1580 (1990).
84. Härkönen T, Lankinen H, Davydova B, Hovi T, Roivainen M. Enterovirus infection can induce immune responses that cross-react with b-cell autoantigen tyrosine phosphatase IA-2/IAR. J. Med. Virol. 66, 340-350 (2002). (Pubitemid 34111775)
85. Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Invest. 114(9), 1290-1298 (2004). (Pubitemid 40385300)
86. Geenen V, Mottet M, Dardenne O et al. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against Type 1 diabetes. Curr. Opin. Pharmacol. 10(4),461-472 (2010).
87. Kecha-Kamoun O, Achour I, Martens H et al. Thymic expression of insulin-related genes in an animal model of autoimmune Type 1 diabetes. Diabetes Metab. Res. Rev. 17(2), 146-152 (2001). (Pubitemid 32427963)
88. Geenen V, Kroemer G. Multiple ways to cellular immune tolerance. Immunol. Today 14(12), 573-575 (1993). (Pubitemid 23349613)
89. Chatterjee NK, Hou J, Dockstader P, Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J. Med. Virol. 38(2), 124-131 (1993).
90. Brilot F, Chehadeh W, Charlet-Renard C, Martens H, Geenen V, Hober D. Persistent infection of human thymic epithelial cells by coxsackievirus B4 J. Virol. 76(10), 5260-5265 (2002). (Pubitemid 34441728)
91. Jaïdane H, Gharbi J, Lobert PE et al. Prolonged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiol. Immunol. 50(12), 971-974 (2006). (Pubitemid 44974653)
92. Brilot F, Geenen V, Hober D, Stoddart CA. Coxsackievirus B4 infection of human fetal thymus cells. J. Virol. 78(18), 9854-9861 (2004). (Pubitemid 39187105)
93. Brilot F, Jaïdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J. Med. Virol. 80(4), 659-66 (2008). (Pubitemid 351358564)
94. Takada A, Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 13(6), 387-398 (2003). (Pubitemid 37413260)
95. Hober D, Chehadeh W, Bouzidi A, Wattré P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-a synthesis. J. Infect. Dis. 184(9), 1098-1108 (2001). (Pubitemid 33010461)
96. Chehadeh W, Bouzidi A, Alm G, Wattré P, Hober D. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-a by human peripheral blood mononuclear cells in vitro. J. Gen. Virol. 82(Pt 8), 1899-1907 (2001). (Pubitemid 32707554)
97. Sauter P, Lobert PE, Lucas B et al. Role of the capsid protein VP4 in the plasma-dependent enhancement of the coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res. 125(2), 183-190 (2007). (Pubitemid 46589680)
98. Hober D, Chehadeh W, Weill J et al. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-a by peripheral blood mononuclear cells from patients with Type 1 diabetes. J. Gen. Virol. 83(Pt 9), 2169-2176 (2002). (Pubitemid 34993722)
99. Chehadeh W, Lobert PE, Sauter P et al. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of a interferon. J. Virol. 79(22), 13882-13891 (2005). (Pubitemid 41552687)
100. Sauter P, Chehadeh W, Lobert PE et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with Type 1 diabetes. J. Med. Virol. 80(5), 866-878 (2008). (Pubitemid 351500035)
101. Kishimoto C, Kurokawa M, Ochiai H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol. 34(9), 1227-1238 (2002). (Pubitemid 35205168)
102. Girn J, Kavoosi M, Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol. 83(Pt 2), 351-358 (2002). (Pubitemid 34134243)
103. Sauter P, Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect. 11(4), 443-445 (2009).Erratum in: Microbes Infect. 11(14-15), 1219 (2009).
104. Tracy S, Drescher KM, Chapman NM et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76(23), 12097-12111 (2002). (Pubitemid 35304309)
105. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from Type 1 diabetes in mice. J. Clin. Invest. 119(6), 1515-1523 (2009).
106. Tracy S, Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J. Med. Virol. 62(1), 70-81 (2000).
107. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and Type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology 329(2), 381-394 (2004). (Pubitemid 39423987)
108. Bach JF. Infections and autoimmune diseases. J. Autoimmun. 25(Suppl.), 74-80 (2005).
109. Tracy S, Drescher KM, Jackson JD, Kim K, Kono K. Enteroviruses, Type 1 diabetes and hygiene: a complex relationship. Rev. Med. Virol. 20(2), 106-116 (2010).
110. TEDDY Study Group. The Environmental Determinents of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes 8, 286-298 (2007).